1. Home
  2. KRYS vs IPAR Comparison

KRYS vs IPAR Comparison

Compare KRYS & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • IPAR
  • Stock Information
  • Founded
  • KRYS 2015
  • IPAR 1982
  • Country
  • KRYS United States
  • IPAR United States
  • Employees
  • KRYS N/A
  • IPAR N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • IPAR Package Goods/Cosmetics
  • Sector
  • KRYS Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • KRYS Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • KRYS 4.7B
  • IPAR 3.9B
  • IPO Year
  • KRYS 2017
  • IPAR 1988
  • Fundamental
  • Price
  • KRYS $183.36
  • IPAR $94.50
  • Analyst Decision
  • KRYS Strong Buy
  • IPAR Strong Buy
  • Analyst Count
  • KRYS 9
  • IPAR 4
  • Target Price
  • KRYS $203.22
  • IPAR $162.00
  • AVG Volume (30 Days)
  • KRYS 384.0K
  • IPAR 317.5K
  • Earning Date
  • KRYS 11-03-2025
  • IPAR 11-05-2025
  • Dividend Yield
  • KRYS N/A
  • IPAR 3.39%
  • EPS Growth
  • KRYS 36.22
  • IPAR 14.29
  • EPS
  • KRYS 4.91
  • IPAR 5.02
  • Revenue
  • KRYS $359,205,000.00
  • IPAR $1,458,888,000.00
  • Revenue This Year
  • KRYS $34.33
  • IPAR $4.18
  • Revenue Next Year
  • KRYS $47.84
  • IPAR $5.29
  • P/E Ratio
  • KRYS $37.38
  • IPAR $18.83
  • Revenue Growth
  • KRYS 116.08
  • IPAR 7.04
  • 52 Week Low
  • KRYS $122.80
  • IPAR $92.46
  • 52 Week High
  • KRYS $207.84
  • IPAR $148.15
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 76.57
  • IPAR 23.60
  • Support Level
  • KRYS $158.08
  • IPAR $92.46
  • Resistance Level
  • KRYS $183.36
  • IPAR $101.51
  • Average True Range (ATR)
  • KRYS 6.02
  • IPAR 2.37
  • MACD
  • KRYS 2.37
  • IPAR -0.50
  • Stochastic Oscillator
  • KRYS 99.31
  • IPAR 14.43

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: